BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18957398)

  • 1. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
    Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
    J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and drug resistance of Acinetobacter baumannii isolated from a regional hospital in the Brazilian Amazon region.
    Ribeiro EA; Gales AC; Oliveira APS; Coelho DD; Oliveira RA; Pfrimer IAH; Carmo Filho JRD
    Rev Soc Bras Med Trop; 2020; 54():e20200087. PubMed ID: 33206875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
    Poirel L; Corvec S; Rapoport M; Mugnier P; Petroni A; Pasteran F; Faccone D; Galas M; Drugeon H; Cattoir V; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2179-84. PubMed ID: 17420213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic characterization and clonal relatedness of metallo-β-lactamase-producing non-fermentative gram negative bacteria in the first 5 years of their circulation in Paraguay (2011-2015).
    Franco R; de Oliveira Santos IC; Mora MFM; López PVA; Alvarez VET; Arce FHO; Lird G; Silvagni M; Kawabata A; Fariña MCR; Fernández MFA; Oliveira TRTE; Rocha-de-Souza CM; Assef APAC
    Braz J Microbiol; 2023 Mar; 54(1):179-190. PubMed ID: 36564646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.
    Brisse S; Milatovic D; Fluit AC; Kusters K; Toelstra A; Verhoef J; Schmitz FJ
    J Clin Microbiol; 2000 Oct; 38(10):3636-45. PubMed ID: 11015376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii.
    Chiu CH; Lee YT; Wang YC; Yin T; Kuo SC; Yang YS; Chen TL; Lin JC; Wang FD; Fung CP
    BMC Infect Dis; 2015 Sep; 15():400. PubMed ID: 26423424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Providencia spp. clinical isolates co-producing carbapenemases IMP-27, OXA-24, and OXA-58 in Mexico.
    Bocanegra-Ibarias P; Duran-Bedolla J; Silva-Sánchez J; Garza-Ramos U; Sánchez-Pérez A; Garza-Gonzáles E; Morfín-Otero R; Barrios-Camacho H
    Diagn Microbiol Infect Dis; 2024 May; 109(1):116246. PubMed ID: 38452556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021.
    Lee YL; Wang WY; Ko WC; Hsueh PR
    J Antimicrob Chemother; 2024 May; ():. PubMed ID: 38758189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Existence of Carbapenemase-Encoding Genes in Acinetobacter baumannii from Cancer Patients.
    Wasfi R; Rasslan F; Hassan SS; Ashour HM; Abd El-Rahman OA
    Infect Dis Ther; 2021 Mar; 10(1):291-305. PubMed ID: 33180321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022.
    Wise MG; Karlowsky JA; Mohamed N; Hermsen ED; Kamat S; Townsend A; Brink A; Soriano A; Paterson DL; Moore LSP; Sahm DF
    J Glob Antimicrob Resist; 2024 Jun; 37():168-175. PubMed ID: 38608936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete sequence of carbapenem-resistant
    Hayashi W; Kaiju H; Kayama S; Yu L; Zuo H; Sugawara Y; Azuma K; Takahashi A; Hata Y; Sugai M
    Microbiol Spectr; 2024 Apr; 12(4):e0391923. PubMed ID: 38483476
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Aguilar-Vera A; Bello-López E; Pantoja-Nuñez GI; Rodríguez-López GM; Morales-Erasto V; Castillo-Ramírez S
    mSphere; 2024 May; 9(5):e0016224. PubMed ID: 38606973
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonal dissemination of Acinetobacter radioresistens among Humboldt penguins (Spheniscus humboldti) inhabiting a barren northern Peruvian island.
    Roca I; Espinoza K; Irigoin-Lovera C; Piquet M; Palomino-Kobayashi LA; Castillo AK; Gonzales-DelCarpio DD; Viñes J; Muñoz L; Ymaña B; Oporto R; Zavalaga C; Pons MJ; Ruiz J
    Eur J Microbiol Immunol (Bp); 2024 May; 14(2):210-218. PubMed ID: 38483509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of
    Banerjee T; Pal S; Das A
    J Lab Physicians; 2017; 9(1):64-65. PubMed ID: 28042221
    [No Abstract]   [Full Text] [Related]  

  • 15. OXA β-lactamases.
    Evans BA; Amyes SG
    Clin Microbiol Rev; 2014 Apr; 27(2):241-63. PubMed ID: 24696435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii.
    Karah N; Sundsfjord A; Towner K; Samuelsen Ø
    Drug Resist Updat; 2012 Aug; 15(4):237-47. PubMed ID: 22841809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global spread of carbapenem-resistant Acinetobacter baumannii.
    Higgins PG; Dammhayn C; Hackel M; Seifert H
    J Antimicrob Chemother; 2010 Feb; 65(2):233-8. PubMed ID: 19996144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of two combined β-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii.
    Domínguez AV; Panadero IM; Smani Y
    Eur J Clin Microbiol Infect Dis; 2023 Nov; 42(11):1317-1325. PubMed ID: 37709968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Intersection of Biocide Resistance, Efflux Pumps, and Sequence Types in Carbapenem-Resistant
    Taj Z; Rasool MH; Khurshid M; Aslam B; Qamar MU
    Pathogens; 2023 Jun; 12(7):. PubMed ID: 37513746
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel strategy to characterize the pattern of β-lactam antibiotic-induced drug resistance in Acinetobacter baumannii.
    Hillyer T; Benin BM; Sun C; Aguirre N; Willard B; Sham YY; Shin WS
    Sci Rep; 2023 Jun; 13(1):9177. PubMed ID: 37280269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.